Hemp Regulation and Safety Standards

Summary#

This bill is a federal law proposal to tightly regulate hemp and products made from hemp. It redefines what counts as hemp, bans many artificially altered cannabinoids, creates new food and labeling rules for hemp-derived cannabinoid products, sets taxes and permits for makers and wholesalers, and adds age and interstate-commerce rules. The stated goal is to protect consumers (especially children), keep lawful hemp commerce viable, and limit high-THC synthetic intoxicants.

• Main change: Redefines “hemp” and excludes many artificially modified cannabinoids (examples named include HHC, THC‑O‑acetate, THCP) from being treated as hemp.
• FDA rules: Treats hemp-derived cannabinoid products as “food,” requires testing by ISO/IEC 17025‑accredited labs, sets labeling and warning requirements, and requires the FDA to set maximum cannabinoid amounts (with default limits if the FDA misses its deadline).
• Age and sourcing limits: Prohibits sale, possession, or use of hemp-derived cannabinoid products by anyone under 21 and requires such products in interstate commerce to be fully sourced and finished within the United States.
• Taxes and permits: Creates a new federal tax system: beverages taxed by THC milligrams (5 cents per mg), other hemp products taxed at 5% of sale price, and a 5% tax on manufacturers’ annual sales revenue; requires manufacturer and wholesaler permits, records, and a three‑tier distribution system for beverages.
• Criminal and civil penalties: Adds civil fines and criminal penalties for violations, including possible imprisonment for serious fraud or evasion.
• Other: Creates a trust fund from these taxes to pay for oversight, directs 1% of beverage tax receipts into the Highway Trust Fund for impaired‑driving support, and allows Medicare Advantage plans to offer hemp‑derived cannabinoid products as a supplemental benefit for the chronically ill.

What it means for you#

• Consumers / Adults (21+):

  • Products must show THC milligrams per serving and per package and carry a government warning.
  • Some cannabinoids and products (including many synthetic or chemically altered cannabinoids) would be excluded from being legal hemp products.
  • You cannot buy or possess hemp‑derived cannabinoid products if you are under 21.

• Patients and Medicare Advantage enrollees:

  • Medicare Advantage plans may be allowed to cover certain hemp‑derived cannabinoid products as a supplemental benefit for chronically ill enrollees, subject to criteria the agency sets.
  • The bill also creates a program under certain federal healthcare models to offer consultations and, in some cases, products as an incentive.

• Hemp farmers and ingredient suppliers:

  • The bill defines industrial hemp and sets an explicit THC ceiling for hemp (in the bill text it is up to 1% total THC on a dry weight basis for hemp parts).
  • Selling unfinished hemp‑cannabinoid ingredients to anyone other than a permitted manufacturer would be unlawful. This limits who can buy intermediate extracts.

• Manufacturers, wholesalers, and retailers:

  • Manufacturers and wholesalers must obtain federal permits, keep inventories and records, and meet testing and labeling rules.
  • Hemp beverages must flow through a three‑tier system (manufacturer → wholesaler → retailer); a single firm may not operate in more than one tier.
  • Manufacturers must pay taxes at specified rates and will be subject to inspections and penalties for violations.

• Businesses importing or using foreign processing:

  • Hemp‑derived cannabinoid products in interstate commerce must be cultivated, processed, finished, packaged, and labeled in the United States. This could prevent using foreign suppliers for finished products.

• State governments and law enforcement:

  • States keep authority to set stricter rules within their borders.
  • Federal highway funding can be reduced for states that do not adopt the bill’s required impaired‑driving standards for hemp impairment (a 10% withholding tied to certain highway funds).
  • The bill pushes states to enforce hemp impairment under the same field sobriety protocols as other impairing medications.

Expenses#

No publicly available information on an official cost estimate or fiscal note accompanies the bill text.

• The bill creates new federal tax revenue streams: a per‑milligram THC tax on hemp beverages (5¢ per mg), a 5% sales tax on non‑beverage hemp cannabinoid products, and a 5% tax on manufacturers’ annual sales revenue.
• Those tax receipts are directed partly to a new Trust Fund for Oversight of Hemp‑derived Cannabinoid Products to pay for regulation and oversight.
• The bill directs 1% of hemp beverage tax receipts to the Highway Trust Fund for impaired‑driving support.
• Compliance costs for business: permits, ISO/IEC 17025 lab testing, inventory and recordkeeping, packaging/labeling changes, and any changes needed to meet domestic sourcing rules.
• Enforcement costs for federal agencies and potential costs to states for changing impaired‑driving laws or enforcement; these are not quantified in the bill text.
• Penalties and criminal enforcement could generate administrative and court costs; statutory fine and imprisonment amounts are specified in the bill.

Proponents' View#

(The following points are drawn from the bill’s stated purposes and its rules. They describe what the bill appears intended to do.)

• The bill appears intended to protect children and young people by setting a uniform federal minimum age (21) and limiting marketing and packaging that appeals to youth.
• It appears intended to remove synthetic or chemically modified cannabinoids from the legal hemp market to reduce exposure to novel, potentially risky intoxicants.
• The bill appears intended to increase consumer safety through testing, uniform labeling (including exact THC milligrams), and mandatory warnings and certificates of analysis.
• It appears intended to support domestic supply chains and quality control by requiring hemp products in interstate commerce to be grown, processed, and finished in the United States.
• The taxes created are intended to fund federal oversight and consumer‑protection activities and to support impaired‑driving enforcement.

Opponents' View#

(The following are reasonable concerns or trade-offs that follow from the bill’s design as written.)

• One concern is that the domestic‑only sourcing rule for interstate commerce could disrupt existing supply chains, raise costs, or make some products unavailable if producers rely on foreign processing.
• One concern is that permit requirements, mandatory laboratory standards, labeling rules, and a new tax regime may impose significant compliance costs, especially on small producers and retailers.
• One concern is the broad discretion given to the Secretary to decide which cannabinoids or production methods “pose a risk” or are excluded; this could create uncertainty for businesses while lists and rules are developed.
• One concern is the criminal penalties for some violations (including possible imprisonment and high fines) and how they would be applied in practice.
• One concern is that the three‑tier distribution requirement for beverages restricts business models (for example, limiting vertical integration) and could raise distribution costs.
• It is unclear how the FDA will set maximum cannabinoid levels in different product forms and how quickly the agency will act; default limits apply only if the agency misses its deadline.